363 related articles for article (PubMed ID: 31650528)
41. Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition.
Bast T; Pezze M; McGarrity S
Br J Pharmacol; 2017 Oct; 174(19):3211-3225. PubMed ID: 28477384
[TBL] [Abstract][Full Text] [Related]
42. Mitochondrial pharmacology: featured mechanisms and approaches for therapy translation.
Wang X; Galli G; Campanella M
Br J Pharmacol; 2019 Nov; 176(22):4245-4246. PubMed ID: 31793696
[TBL] [Abstract][Full Text] [Related]
43. Neuroprotective Herbs for the Management of Alzheimer's Disease.
Gregory J; Vengalasetti YV; Bredesen DE; Rao RV
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33917843
[TBL] [Abstract][Full Text] [Related]
44. Editorial for GPR84 pharmacology.
Milligan G
Br J Pharmacol; 2024 May; 181(10):1497-1499. PubMed ID: 38456201
[TBL] [Abstract][Full Text] [Related]
45. Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues.
Ittner LM; Klugmann M; Ke YD
Br J Pharmacol; 2019 Sep; 176(18):3649-3665. PubMed ID: 30817847
[TBL] [Abstract][Full Text] [Related]
46. Dietary supplements and medicinal plants in urolithiasis: diet, prevention, and cure.
Oswal M; Varghese R; Zagade T; Dhatrak C; Sharma R; Kumar D
J Pharm Pharmacol; 2023 Jun; 75(6):719-745. PubMed ID: 37130140
[TBL] [Abstract][Full Text] [Related]
47. Brain Food for Alzheimer-Free Ageing: Focus on Herbal Medicines.
Hügel HM
Adv Exp Med Biol; 2015; 863():95-116. PubMed ID: 26092628
[TBL] [Abstract][Full Text] [Related]
48. The potential health effects of dietary phytoestrogens.
Rietjens IMCM; Louisse J; Beekmann K
Br J Pharmacol; 2017 Jun; 174(11):1263-1280. PubMed ID: 27723080
[TBL] [Abstract][Full Text] [Related]
49. Medicinal Herbs and Nutritional Supplements for Dementia Therapy: Potential Targets and Clinical Evidence.
Dorman G; Flores I; Gutiérrez C; Castaño RF; Aldecoa M; Kim L
CNS Neurol Disord Drug Targets; 2022; 21(1):26-51. PubMed ID: 34370647
[TBL] [Abstract][Full Text] [Related]
50. Molecular pharmacology of GPCRs.
Langmead CJ; Summers RJ
Br J Pharmacol; 2018 Nov; 175(21):4005-4008. PubMed ID: 30302756
[TBL] [Abstract][Full Text] [Related]
51. Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.
Dauvermann MR; Lee G; Dawson N
Br J Pharmacol; 2017 Oct; 174(19):3136-3160. PubMed ID: 28626937
[TBL] [Abstract][Full Text] [Related]
52. Clinical relevance of St. John's wort drug interactions revisited.
Nicolussi S; Drewe J; Butterweck V; Meyer Zu Schwabedissen HE
Br J Pharmacol; 2020 Mar; 177(6):1212-1226. PubMed ID: 31742659
[TBL] [Abstract][Full Text] [Related]
53. Medicinal plants and bioactive natural compounds as inhibitors of HMG-CoA reductase: A literature review.
Mahdavi A; Bagherniya M; Fakheran O; Reiner Ž; Xu S; Sahebkar A
Biofactors; 2020 Nov; 46(6):906-926. PubMed ID: 33053603
[TBL] [Abstract][Full Text] [Related]
54. The role of phytochemicals as micronutrients in health and disease.
Howes MJ; Simmonds MS
Curr Opin Clin Nutr Metab Care; 2014 Nov; 17(6):558-66. PubMed ID: 25252018
[TBL] [Abstract][Full Text] [Related]
55. Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure.
d'Angelo LC; Savulich G; Sahakian BJ
Br J Pharmacol; 2017 Oct; 174(19):3257-3267. PubMed ID: 28427114
[TBL] [Abstract][Full Text] [Related]
56. Treating Alzheimer's disease by targeting iron.
Nikseresht S; Bush AI; Ayton S
Br J Pharmacol; 2019 Sep; 176(18):3622-3635. PubMed ID: 30632143
[TBL] [Abstract][Full Text] [Related]
57. Possible mechanisms of cancer prevention by nicotinamide.
Buqué A; Bloy N; Kroemer G; Galluzzi L
Br J Pharmacol; 2021 May; 178(10):2034-2040. PubMed ID: 32383227
[TBL] [Abstract][Full Text] [Related]
58. Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer's Disease.
Dominguez LJ; Barbagallo M
Curr Pharm Des; 2016; 22(6):688-700. PubMed ID: 26635270
[TBL] [Abstract][Full Text] [Related]
59. The pro-cognitive mechanisms of physical exercise in people with schizophrenia.
Firth J; Cotter J; Carney R; Yung AR
Br J Pharmacol; 2017 Oct; 174(19):3161-3172. PubMed ID: 28261797
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
